New research results from a COAPT study examined the effect MitraClip had on heart failure patients.
New research results from a COAPT study examined the effect MitraClip had on heart failure patients.
Baylor Scott & White Heart & Vascular Hospital – Dallas is currently enrolling patients for a prospective, multicenter, single-arm, global investigational device exemption (IDE) study to evaluate the safety and effectiveness of the Shockwave Coronary IVL System in de novo, calcified, stenotic coronary arteries prior to stenting. Disrupt CAD III is being conducted as a staged pivotal study.
Baylor Scott & White All Saints Medical Center – Fort Worth is currently enrolling patients for a study designed to assess the impact of the Multi Point Pacing (MPP) feature at 12 months in the treatment of patients not responding to standard Cardiac Resynchronization Therapy (CRT) after 6 months.
Despite the availability of pulmonary arterial hypertension (PAH)-targeted therapeutic options over the past twenty years, there is general consensus around shortcomings with regards to PAH diagnosis and management.
Researchers recently published findings based on secondary analysis of a study, HF-ACTION, examining the impact of structured aerobic exercise on patients with long-term heart failure with reduced ejection fraction (HFrEF). The secondary analysis applied the association of baseline chronic liver disease (CLD) on the benefits of structured aerobic exercise for the patients.